July tests investor conviction. From the 2011 debt-ceiling standoff to the 2022 inflation shock, summer volatility has separated durable businesses from cyclical hopefuls. Three consumer staples and healthcare giants have paid and raised dividends through Black Monday 1987, the dot-com crash, the 2008 financial crisis, the COVID-19 shutdown and the 2022 bear market. Each is a Dividend King with a decades-long streak, and each delivered a beat-and-raise quarter heading into the back half of 2026.
This is the crisis-resilience watchlist for July 2026: three names that keep writing checks when the market stops working.
Coca-Cola (KO)
Coca-Cola (NYSE:KO | KO Price Prediction) enters summer with momentum, with the stock up around 20% year to date as of July 17 along with a market cap near $361.09 billion. Q1 2026 reported April 28 delivering EPS of 86 cents versus the estimated 81 cents on revenue of $12.47 billion, up 12.1% year over year. That was the fourth consecutive EPS beat, with organic revenue up 10%, global unit case volume up 3% and Coca-Cola Zero Sugar volume up 13%. Operating margin expanded to 35.0% from 32.9%.
The bull case: pricing power, scale, and cash return. Management guided 2026 to 4-5% organic revenue growth, 8% to 9% comparable EPS growth, and roughly $12.2 billion in free cash flow. Coca-Cola paid $8.8 billion in dividends in 2025 and has raised the payout for 63 consecutive years. The quarterly dividend stepped to 53 cents in 2026 from 51 cents in 2025. KO raised its quarterly payout to 41 cents in 2009 from 38 cents in 2008, straight through the financial crisis. CEO Henrique Braun said: “We’ve had a strong start to the year. Our performance this quarter reflects our unwavering focus on staying close to the consumer, executing locally and managing complexity.”
Risk to watch for: the pending Coca-Cola Beverages Africa sale, ongoing IRS tax litigation and a roughly 4% headwind from acquisitions and divestitures. Shares trade at a P/E of 28, not cheap for a mid-single-digit growth business.
Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) has been one of the year’s biggest large-cap surprises, up 22.41% year to date and 55.74% over the past year. Q1 2026 reported April 14 posting adjusted EPS of $2.70 versus $2.68 expected on revenue of $24.06 billion, up 9.9% year over year. Innovative Medicine came in at $15.43 billion, up 11.2%, with DARZALEX at $3.96 billion (+22.5%), TREMFYA at $1.61 billion (+68.3%) and CARVYKTI at $597 million (+62.1%).
The dividend track record is the point. JNJ raised its Q2 2026 dividend 3.1% to $1.34 per share, extending the streak to 64 consecutive years of increases. The company kept raising the payout through the COVID-19 crash, moving from $0.95 in Q1 2020 to $1.01 in Q2 2020. Management raised 2026 guidance to revenue of $100.3 billion to $101.3 billion and adjusted EPS of $11.45 to $11.65. CEO Joaquin Duato said: “Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact.” Composite prediction-market sentiment sits at 60.67, bullish with medium confidence.
Risk to watch for: STELARA biosimilar erosion drove that franchise down 59.7% to $656 million in Q1, litigation charges added $330 million in the quarter, and the planned Orthopaedics separation introduces execution risk. For income investors weighing multi-decade streaks, our 10 Dividend Kings research walks through how these compounders behave across full market cycles.
Procter & Gamble (PG)
Procter & Gamble (NYSE:PG) is the least exciting name on this list, and that is the point. Fiscal Q3 2026 reported April 24 producing core EPS of $1.59 versus $1.56 estimated on net sales of $21.24 billion, up 7.4% year over year. Organic sales rose 3%, Beauty jumped 7% organic and growth was broad across all five segments. That makes four straight quarters of top- and bottom-line beats.
The dividend streak stands at 70 consecutive annual increases and 136 consecutive years of dividend payments since incorporation in 1890. The Q2 2026 payout was raised to $1.0885 per quarter from $1.0568. FY2026 plans include roughly $10 billion in dividends and about $5 billion in share repurchases. Beta of 0.38 makes PG one of the lowest-volatility large caps in the S&P 500. Reddit sentiment reads bullish at 72, with a composite score of 67.15. CEO Shailesh Jejurikar said the quarter delivered “a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions.”
Risk to watch for: P&G expects FY2026 core EPS to land toward the lower end of its $6.83 to $7.09 range due to roughly $400 million in after-tax tariff costs and a $150 million commodity headwind. Core gross margin slipped 100 basis points. Shares are up just 5.03% year to date, but that muted move is what defensive investors want when volatility strikes.
What to Watch Next
All three cleared Q1 with beats, raised dividends in 2026, and carry crisis track records predating most current Wall Street portfolio managers. If July delivers another volatility shock, keep an eye on these three: History says the checks keep clearing regardless of headlines.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks